Internationa Flavors & Fragrances Stock Earnings Reports

IFF reported a solid start to FY2026 with Q1 revenue just over $2.7 billion, driven by volume growth across all segments. Sales rose ~3% (currency-neutral): Health & Biosciences led with mid-single-digit growth, Taste, Food Ingredients and Scent grew low single digits. Adjusted operating EBITDA was $568 million, up 8% year-over-year, with adjusted EBITDA margin improving ~110 bps to 20.7% (highest since Q2 2022). Cash flow from operations improved to $257 million and first-quarter free cash flow was $92 million (up $144 million YoY). Gross debt fell to $5.85 billion and net debt/adjusted EBITDA ended Q1 at ~2.5x. Strategic progress includes the March divestiture of a commodity soy business to Bunge for $110 million and an active sale process for the Food Ingredients division (management expects an update by the Q2 call). Management reiterated full-year 2026 guidance: sales $10.5–10.8 billion (1–4% growth) and adjusted operating EBITDA $2.05–2.15 billion (3–8% growth), while noting FX should contribute ~1 percentage point to sales. Management warned of near-term headwinds: inflation (energy/logistics first, raw material inflation later) and disruption to Fine Fragrance volumes in the Middle East—Q2 EBITDA is expected to be lower than Q1 as pricing surcharges are phased in and mix/volume pressures occur. The company remains focused on productivity, disciplined capital allocation, supporting innovation and commercial pipelines, and returning cash to shareholders.